Manufacturer of Controlled Substances; Notice of Application, 41838-41839 [E6-11691]
Download as PDF
<![CDATA[
41838
Federal Register / Vol. 71, No. 141 / Monday, July 24, 2006 / Notices
Drug
Schedule
4-Methoxyamphetamine (7411) ...................................................................................................................................................................
Dimethyltryptamine (7435) ..........................................................................................................................................................................
Psilocybin (7437) .........................................................................................................................................................................................
Psilocyn (7438) ............................................................................................................................................................................................
Acetyldihydrocodeine (9051) .......................................................................................................................................................................
Dihydromorphine (9145) ..............................................................................................................................................................................
Heroin (9200) ...............................................................................................................................................................................................
Normorphine (9313) ....................................................................................................................................................................................
Pholcodine (9314) .......................................................................................................................................................................................
Tilidine (9750) ..............................................................................................................................................................................................
Amphetamine (1100) ...................................................................................................................................................................................
Methamphetamine (1105) ...........................................................................................................................................................................
Amobarbital (2125) ......................................................................................................................................................................................
Pentobarbital (bulk) (2270) ..........................................................................................................................................................................
Secobarbital (2315) .....................................................................................................................................................................................
Phencyclidine (7471) ...................................................................................................................................................................................
Cocaine (9041) ............................................................................................................................................................................................
Codeine (9050) ............................................................................................................................................................................................
Dihydrocodeine (9120) ................................................................................................................................................................................
Oxycodone (9143) .......................................................................................................................................................................................
Hydromorphone (9150) ...............................................................................................................................................................................
Benzoylecgonine (9180) ..............................................................................................................................................................................
Ethylmorphine (9190) ..................................................................................................................................................................................
Hydrocodone (9193) ....................................................................................................................................................................................
Levorphanol (9220) .....................................................................................................................................................................................
Meperidine (9230) .......................................................................................................................................................................................
Methadone (9250) .......................................................................................................................................................................................
Dextropropoxyphene, bulk (9273) ...............................................................................................................................................................
Morphine (9300) ..........................................................................................................................................................................................
Thebaine (9333) ..........................................................................................................................................................................................
Oxymorphone (9652) ...................................................................................................................................................................................
Alfentanil (9737) ..........................................................................................................................................................................................
Fentanyl (9801) ...........................................................................................................................................................................................
Sufentanil (9740) .........................................................................................................................................................................................
sroberts on PROD1PC70 with NOTICES
The company plans to import
analytical reference standards for
distribution to its customers for research
and analytical purposes.
Any manufacturer who is presently,
or is applying to be, registered with DEA
to manufacture such basic classes of
controlled substances may file
comments or objections to the issuance
of the proposed registration and may, at
the same time, file a written request for
a hearing on such application pursuant
to 21 CFR 1301.43 and in such form as
prescribed by 21 CFR 1316.47.
Any such written comments or
objections being sent via regular mail
may be addressed, in quintuplicate, to
the Deputy Assistant Administrator,
Office of Diversion Control, Drug
Enforcement Administration,
Washington, DC 20537, Attention: DEA
Federal Register Representative, Liaison
and Policy Section (ODL); or any being
sent via express mail should be sent to
DEA Headquarters, Attention: DEA
Federal Register Representative/ODL,
2401 Jefferson-Davis Highway,
Alexandria, Virginia 22301; and must be
filed no later than August 23, 2006.
This procedure is to be conducted
simultaneously with and independent
of the procedures described in 21 CFR
1301.34(b), (c), (d), (e) and (f). As noted
in a previous notice published in the
Federal Register on September 23, 1975,
(40 FR 43745–46), all applicants for
registration to import a basic class of
any controlled substance listed in
Schedule I or II are, and will continue
to be required to demonstrate to the
Deputy Assistant Administrator, Office
of Diversion Control, Drug Enforcement
Administration, that the requirements
for such registration pursuant to 21
U.S.C. 958(a), 21 U.S.C. 823(a), and 21
CFR 1301.34(b), (c), (d), (e), and (f) are
satisfied.
Dated: July 10, 2006.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. E6–11688 Filed 7–21–06; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled
Substances; Notice of Application
Pursuant to § 1301.33(a) of Title 21 of
the Code of Federal Regulations (CFR),
this is notice that on January 26, 2006,
Sigma Aldrich Research BioChemicals,
Inc., 1–3 Strathmore Road, Natick,
Massachusetts 01760, made application
by renewal to the Drug Enforcement
Administration (DEA) to be registered as
a bulk manufacturer of the basic classes
of controlled substances listed in
Schedules I and II:
Drug
Schedule
Cathinone (1235) .........................................................................................................................................................................................
Methcathinone (1237) ..................................................................................................................................................................................
Aminorex (1585) ..........................................................................................................................................................................................
Alpha-ethyltryptamine (7249) ......................................................................................................................................................................
VerDate Aug<31>2005
17:54 Jul 21, 2006
Jkt 208001
PO 00000
Frm 00085
Fmt 4703
I
I
I
I
I
I
I
I
I
I
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
Sfmt 4703
E:\FR\FM\24JYN1.SGM
24JYN1
I
I
I
I
41839
Federal Register / Vol. 71, No. 141 / Monday, July 24, 2006 / Notices
Drug
Schedule
Lysergic acid diethylamide (7315) ...............................................................................................................................................................
Tetrahydrocannabinols (7370) .....................................................................................................................................................................
4-Bromo-2, 5-dimethoxy-amphetamine (7391) ...........................................................................................................................................
4-Bromo-2, 5-dimethoxyphenethylamine (7392) .........................................................................................................................................
2, 5-Dimethoxyamphetamine (7396) ...........................................................................................................................................................
3,4-Methylenedioxyamphetamine (7400) ....................................................................................................................................................
N-Hydroxy-3,4-methylenedioxyamphetamine (7402) ..................................................................................................................................
3,4-Methylenedioxy-N-ethylamphetamine (7404) ........................................................................................................................................
3,4-Methylenedioxymethamphetamine (MDMA) (7405) ..............................................................................................................................
1-[1-2-Thienyl) cyclohexyl]phetamine (TCP) (7470) ...................................................................................................................................
1-Benzylpiperazine (BZP) (7493) ................................................................................................................................................................
Heroin (9200) ...............................................................................................................................................................................................
Normorphine (9313) ....................................................................................................................................................................................
Amphetamine (1100) ...................................................................................................................................................................................
Methamphetamine (1105) ...........................................................................................................................................................................
Nabilone (7379) ...........................................................................................................................................................................................
1-Phenylcyclohexylamine (7460) .................................................................................................................................................................
Phencyclidine (7471) ...................................................................................................................................................................................
Cocaine (9041) ............................................................................................................................................................................................
Codeine (9050) ............................................................................................................................................................................................
Diprenorphine (9058) ...................................................................................................................................................................................
Ecgonine (9180) ..........................................................................................................................................................................................
Levomethorphan (9210) ..............................................................................................................................................................................
Levorphanol (9220) .....................................................................................................................................................................................
Meperidine (9230) .......................................................................................................................................................................................
Metazocine (9240) .......................................................................................................................................................................................
Methadone (9250) .......................................................................................................................................................................................
Morphine (9300) ..........................................................................................................................................................................................
Thebaine (9333) ..........................................................................................................................................................................................
Levo-alphacetylmethadol (9648) .................................................................................................................................................................
Carfentanil (9743) ........................................................................................................................................................................................
Fentanyl (9801) ...........................................................................................................................................................................................
sroberts on PROD1PC70 with NOTICES
The company plans to manufacture
reference standards.
Any other such applicant and any
person who is presently registered with
DEA to manufacture such a substance
may file comments or objections to the
issuance of the proposed registration
pursuant to 21 CFR 1301.33(a).
Any such written comments or
objections being sent via regular mail
may be addressed, in quintuplicate, to
the Deputy Assistant Administrator,
Office of Diversion Control, Drug
Enforcement Administration,
Washington, DC 20537, Attention: DEA
Federal Register Representative, Liaison
and Policy Section (ODL); or any being
sent via express mail should be sent to
DEA Headquarters, Attention: DEA
Federal Register Representative/ODL,
2401 Jefferson-Davis Highway,
Alexandria, Virginia 22301; and must be
filed no later than September 22, 2006.
Dated: July 10, 2006.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. E6–11691 Filed 7–21–06; 8:45 am]
BILLING CODE 4410–09–P
VerDate Aug<31>2005
17:54 Jul 21, 2006
Jkt 208001
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Importer of Controlled Substances;
Notice of Application
Pursuant to 21 U.S.C. 958(i), the
Attorney General shall, prior to issuing
a registration under this Section to a
bulk manufacturer of a controlled
substance in Schedule I or II and prior
to issuing a regulation under 21 U.S.C.
952(a)(2)(B) authorizing the importation
of such a substance, provide
manufacturers holding registrations for
the bulk manufacture of the substance
an opportunity for a hearing.
Therefore, in accordance with 21 CFR
1301.34(a), this is notice that on January
24, 2006, Stepan Company, Natural
Products Department., 100 W. Hunter
Avenue, Maywood, New Jersey 07607,
made application by renewal to the
Drug Enforcement Administration
(DEA) to be registered as an importer of
Coca Leaves (9040), a basic class of
controlled substance listed in Schedule
II.
The company plans to import the
listed controlled substance for the
manufacture of bulk controlled
substances and distribution to its
customer.
Any manufacturer who is presently,
or is applying to be, registered with DEA
PO 00000
Frm 00086
Fmt 4703
Sfmt 4703
I
I
I
I
I
I
I
I
I
I
I
I
I
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
to manufacture such basic classes of
controlled substances may file
comments or objections to the issuance
of the proposed registration and may, at
the same time, file a written request for
a hearing on such application pursuant
to 21 CFR 1301.43 and in such form as
prescribed by 21 CFR 1316.47.
Any such written comments or
objections being sent via regular mail
may be addressed, in quintuplicate, to
the Deputy Assistant Administrator,
Office of Diversion Control, Drug
Enforcement Administration,
Washington, DC 20537, Attention: DEA
Federal Register Representative, Liaison
and Policy Section (ODL); or any being
sent via express mail should be sent to
DEA Headquarters, Attention: DEA
Federal Register Representative/ODL,
2401 Jefferson-Davis Highway,
Alexandria, Virginia 22301; and must be
filed no later than August 23, 2006.
This procedure is to be conducted
simultaneously with and independent
of the procedures described in 21 CFR
1301.34(b), (c), (d), (e) and (f). As noted
in a previous notice published in the
Federal Register on September 23, 1975,
(40 FR 43745–46), all applicants for
registration to import a basic class of
any controlled substance listed in
Schedule I or II are, and will continue
to be required to demonstrate to the
Deputy Assistant Administrator, Office
E:\FR\FM\24JYN1.SGM
24JYN1
]]>Agencies
[Federal Register Volume 71, Number 141 (Monday, July 24, 2006)]
[Notices]
[Pages 41838-41839]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E6-11691]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled Substances; Notice of Application
Pursuant to Sec. 1301.33(a) of Title 21 of the Code of Federal
Regulations (CFR), this is notice that on January 26, 2006, Sigma
Aldrich Research BioChemicals, Inc., 1-3 Strathmore Road, Natick,
Massachusetts 01760, made application by renewal to the Drug
Enforcement Administration (DEA) to be registered as a bulk
manufacturer of the basic classes of controlled substances listed in
Schedules I and II:
------------------------------------------------------------------------
Drug Schedule
------------------------------------------------------------------------
Cathinone (1235)................................. I
Methcathinone (1237)............................. I
Aminorex (1585).................................. I
Alpha-ethyltryptamine (7249)..................... I
[[Page 41839]]
Lysergic acid diethylamide (7315)................ I
Tetrahydrocannabinols (7370)..................... I
4-Bromo-2, 5-dimethoxy-amphetamine (7391)........ I
4-Bromo-2, 5-dimethoxyphenethylamine (7392)...... I
2, 5-Dimethoxyamphetamine (7396)................. I
3,4-Methylenedioxyamphetamine (7400)............. I
N-Hydroxy-3,4-methylenedioxyamphetamine (7402)... I
3,4-Methylenedioxy-N-ethylamphetamine (7404)..... I
3,4-Methylenedioxymethamphetamine (MDMA) (7405).. I
1-[1-2-Thienyl) cyclohexyl]phetamine (TCP) (7470) I
1-Benzylpiperazine (BZP) (7493).................. I
Heroin (9200).................................... I
Normorphine (9313)............................... I
Amphetamine (1100)............................... II
Methamphetamine (1105)........................... II
Nabilone (7379).................................. II
1-Phenylcyclohexylamine (7460)................... II
Phencyclidine (7471)............................. II
Cocaine (9041)................................... II
Codeine (9050)................................... II
Diprenorphine (9058)............................. II
Ecgonine (9180).................................. II
Levomethorphan (9210)............................ II
Levorphanol (9220)............................... II
Meperidine (9230)................................ II
Metazocine (9240)................................ II
Methadone (9250)................................. II
Morphine (9300).................................. II
Thebaine (9333).................................. II
Levo-alphacetylmethadol (9648)................... II
Carfentanil (9743)............................... II
Fentanyl (9801).................................. II
------------------------------------------------------------------------
The company plans to manufacture reference standards.
Any other such applicant and any person who is presently registered
with DEA to manufacture such a substance may file comments or
objections to the issuance of the proposed registration pursuant to 21
CFR 1301.33(a).
Any such written comments or objections being sent via regular mail
may be addressed, in quintuplicate, to the Deputy Assistant
Administrator, Office of Diversion Control, Drug Enforcement
Administration, Washington, DC 20537, Attention: DEA Federal Register
Representative, Liaison and Policy Section (ODL); or any being sent via
express mail should be sent to DEA Headquarters, Attention: DEA Federal
Register Representative/ODL, 2401 Jefferson-Davis Highway, Alexandria,
Virginia 22301; and must be filed no later than September 22, 2006.
Dated: July 10, 2006.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. E6-11691 Filed 7-21-06; 8:45 am]
BILLING CODE 4410-09-P
